EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische Studie

Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer

Fatima Cardoso, Susanne Parke, Donal J Brennan, Paula Briggs, Gilbert Donders, Nick Panay, Nazanin Haseli-Mashhadi, Michael Block, Cecilia Caetano, Maja Francuski, Claudia Haberland, Kaisa Laapas und 2 weitere

New England Journal of Medicine · 21.08.2025 · 393 (8) · 753-763

DOI: 10.1056/nejmoa2415566 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 21.08.2025. Verfasst von Fatima Cardoso und 13 weiteren Autor:innen. Beteiligte Einrichtung: Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal. Hauptthemen laut MEDLINE: Antineoplastic Agents, Hormonal, Breast Neoplasms, Hot Flashes, Vasomotor System. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Bayer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agents, HormonalBreast NeoplasmsHot FlashesVasomotor SystemNeurokinin-1 Receptor AntagonistsAdultAgedFemaleHumansMiddle AgedYoung AdultDouble-Blind MethodTamoxifenSeverity of Illness IndexReceptors, Neurokinin-3Aromatase InhibitorsDrug InteractionsTreatment Outcome

Substanzen

Antineoplastic Agents, HormonalTamoxifenNeurokinin-1 Receptor AntagonistsReceptors, Neurokinin-3Aromatase Inhibitors

Autor:innen und Institutionen

  • Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
  • ABC Global Alliance, Lisbon, Portugal.
  • Bayer, Berlin.
  • University College Dublin Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin.
  • Liverpool Women's Hospital, Liverpool, United Kingdom.
  • Department of Clinical Research for Women, Femicare, Tienen, Belgium.

Förderung

  • Bayer

Zitieren

APA

Cardoso, F., Parke, S., Brennan, D. J., Briggs, P., Donders, G., Panay, N., Haseli-Mashhadi, N., Block, M., Caetano, C., Francuski, M., Haberland, C., Laapas, K., Seitz, C., & Zuurman, L. (2025). Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer. New England Journal of Medicine, 393(8), 753-763. https://doi.org/10.1056/nejmoa2415566

Vancouver

Cardoso F, Parke S, Brennan DJ, Briggs P, Donders G, Panay N, et al. Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer. New England Journal of Medicine. 2025;393(8):753-763. doi:10.1056/nejmoa2415566

BibTeX
@article{Cardoso2025,
  author = {Cardoso, Fatima and Parke, Susanne and Brennan, Donal J and Briggs, Paula and Donders, Gilbert and Panay, Nick and Haseli-Mashhadi, Nazanin and Block, Michael and Caetano, Cecilia and Francuski, Maja and Haberland, Claudia and Laapas, Kaisa and Seitz, Christian and Zuurman, Lineke},
  title = {Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {393},
  number = {8},
  pages = {753--763},
  doi = {10.1056/nejmoa2415566}
}
Kostenlos starten →